论文部分内容阅读
目的了解住院糖尿病患者感染鲍曼不动杆菌情况及其耐药性,为有效控制鲍曼不动杆菌感染提供依据。方法采用回顾性调查方法,对本医院住院糖尿病患者合并鲍曼不动杆菌感染情况进行了调查与分析。结果调查期间从1 705份糖尿病患者各种标本中共检出鲍曼不动杆菌138株,分离率为8.09%,且分离率有逐年增加趋势。本次临床分离的鲍曼不动杆菌对该医院临床常用抗菌药物普遍耐药,对多数抗菌药物耐药率超过50%。结论该医院住院糖尿病患者标本鲍曼不动杆菌分离率较高,且普遍耐药。
Objective To understand the situation and drug resistance of Acinetobacter baumannii in hospitalized diabetic patients and provide basis for effective control of Acinetobacter baumannii infection. Methods A retrospective survey was conducted to investigate the prevalence of Acinetobacter baumannii inpatients with diabetes mellitus in our hospital. Results During the investigation, 138 strains of Acinetobacter baumannii were isolated from 1 705 samples of diabetic patients, the isolation rate was 8.09%, and the isolation rate increased year by year. The clinically isolated Acinetobacter baumannii commonly used in the hospital clinically used antimicrobials generally resistant to most antibacterial drug resistance rate of more than 50%. Conclusion The isolation rate of Acinetobacter baumannii in hospitalized patients with diabetes mellitus is high and generally resistant.